About
Dr. Ali Chamseddine is a Consultant Medical Oncologist from France, holding dual board certifications in medical oncology and clinical haematology, as well as MD and PhD degrees. He gained expertise at the esteemed Gustave Roussy Cancer Center in Villejuif, France, where he served as a senior medical oncology consultant. Dr. Chamseddine further honed his skills through a post-doctoral fellowship at the Division of Cancer Medicine, Leukaemia Department, at the renowned MD Anderson Cancer Center in Houston, Texas, USA.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Ali Chamseddine
Education & training
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Oncology
Career & appointments
-
2017-09–2018-08 Junior consultant
Licenses & insurance
Medical licenses
AE — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 5,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 130 |
| Annual physical exam | 99395 | 2,884 |
| Vaccination administration | 90471 | 1,828 |
| Minor procedure (skin) | 17110 | 1,267 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 360.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 11 · i10: 3
-
Validation of clinical scoring in Oncology
DOI: 10.7129/euroclin.2026.0 · PMID: 37579667 · cited by 130
-
Long-term follow-up of Oncology across AE
DOI: 10.5594/euroclin.2025.1 · PMID: 31987343 · cited by 200
-
Validation of clinical scoring in Oncology
DOI: 10.6633/euroclin.2024.2 · PMID: 37865520 · cited by 118
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · Dubai · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — Dubai · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2018
- national college of family doctors — Member · since 2018
- European Union of Medical Specialists (UEMS) — Member · since 2018
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · ali.chamseddine@euroclinics.example
Location
1 tagPatient reviews
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
